Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Talat Almukhtar
Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema
American Journal of Ophthalmology
Ophthalmology
Green or Yellow Laser Treatment for Diabetic Macular Edema
Retina
Medicine
Ophthalmology
Related publications
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Acta Ophthalmologica
Medicine
Ophthalmology
Expanded 2-Year Follow-Up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Ophthalmology
Ophthalmology
Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment
Ophthalmology
Ophthalmology
Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment: 5-Year Randomized Trial Results
Ophthalmology
Ophthalmology
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
Ophthalmology
Ophthalmology
Macular Laser Grid Alone Versus Combined With Intravitreal Triamcinolone Plus Bevacizumab for Diabetic Macular Edema
Journal of Pharmaceutical and Scientific Innovation
Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema
JAMA Ophthalmology
Ophthalmology
Baseline Predictors for One-Year Visual Outcomes With Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration
Ophthalmology
Ophthalmology